|Bid||17.75 x 1200|
|Ask||20.96 x 3000|
|Day's range||19.91 - 20.59|
|52-week range||15.83 - 25.68|
|Beta (5Y monthly)||0.53|
|PE ratio (TTM)||24.60|
|Earnings date||07 Feb 2022 - 11 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||26.83|
It might be of some concern to shareholders to see the Corcept Therapeutics Incorporated ( NASDAQ:CORT ) share price...
Today, we issued a press release announcing our financial results for the first quarter and providing a corporate update. Statements during this call, other than statements of historical fact, are forward-looking statements based on our plans and expectations that are subject to risks and uncertainties, which may cause actual results to differ materially from those such statements expressed or implied.
Corcept's (CORT) earnings as well as revenues miss estimates in the first quarter of 2022.